KMT2A and leukemia: Consequently, research is focused on the development of targeted therapies, including epigenetic modifications, cell cycle checkpoints, and other molecular interventions, such as those affecting cholesterol metabolism, to improve outcomes for patients with MLL-related leukemia [21,22,23].